Elf Beauty (NYSE:ELF) shares moved lower on Monday after the company released the first detailed information following its recent acquisition of Hailey Bieber’s beauty brand Rhode.
Prior to the release, investors knew only that Rhode generated $212 million in annual sales for financial year 2025 and was accretive to gross margin, operating margin, and adjusted EPS, but the level of accretion and recent growth trajectory were largely unknown.
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) announced that it has completed its first-in-human clinical study treating patients with histologically confirmed, immunotherapy-resistant cutaneous metastatic melanoma using Sona's Targeted Hyperthermia Therapy (THT).
The company said by day 15, eight of 10 patients experienced a significant clinical response to treatment with a majority (six out of eight) showing no detectable residual melanoma in representative, biopsied tumors, and two patients showing no response.
Weight management company WW International, also known as WeightWatchers (NASDAQ:WW), has partnered with Amazon Pharmacy to streamline access to weight management medications for WeightWatchers Clinic members.
Under the partnership, members can view real-time medication availability, compare delivery options, and receive prescriptions through Amazon Pharmacy.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) told investors it has signed a US$240 million debt funding agreement for its Tulu Kapi Gold Project in Ethiopia.
The debt was jointly signed by KEFI and its co-lenders as part of the project’s total US$340 million development package, the company confirmed via RNS.
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF) has raised £100,000 through a placing with major shareholder Stuart Packwood to fund further drilling at its Mushima North Project in Zambia.
The placing, arranged via joint broker Peterhouse Capital Limited, saw 153.85 million new shares issued at 0.065p per share.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has cleared a key hurdle in its bid to patent a gene therapy targeting ageing, after the European Patent Office (EPO) confirmed that claims in one of the company's core applications are patentable.
The development means Genflow’s application, covering a variant of the SIRT6 gene, has now entered the final pre-grant stage, a significant step in securing full patent protection across Europe.
NanoViricides (NYSE-A:NNVC) said on Monday its experimental antiviral drug NV-387 showed strong activity against the Measles virus in a humanized animal model, adding that it could be made available for emergency use as outbreaks spread across the US.
The Connecticut-based company said NV-387 increased survival in Measles-infected animals by 130% compared with untreated ones, with no observed signs of toxicity.
Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) has announced that its Lithium Extraction Facility in Amargosa Valley, Nevada, has successfully produced lithium hydroxide for the first time.
The material was derived from lithium carbonate processed from the company’s 100%-owned Angel Island lithium project near Silver Peak, Nevada.
Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) announced final assay results from its 2025 exploration programs at the Corvo Uranium Project, currently under a three-year earn-in option agreement with Aventis Energy Inc.
The uranium exploration company said the results confirm high-grade uranium mineralization at surface across the project, including the historical Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% uranium oxide in outcrop grab samples.
Charbone Hydrogen Corporation (TSX-V:CH, OTCQB:CHHYF) announced that it has entered into a strategic alliance and multiple commercial supply agreements with a major US-based producer and distributor of industrial gases.
The partner company is a subsidiary of a member of one of the world’s largest chemical and industrial conglomerates.
Midnight Sun Mining Corp (TSX-V:MMA, OTCQB:MDNGF) said on Monday it has qualified to trade on the OTCQX Best Market in the US, a move aimed at increasing its visibility and access to American investors.
The Vancouver-based explorer will trade under the ticker ‘MDNGF’ and maintain its primary listing on Canada’s TSX Venture Exchange.
Tap Global shares jumped 33% to 2.97p on Monday after the crypto payments group unveiled a new service aimed at helping public companies manage Bitcoin as part of their corporate reserves.
The company’s new Bitcoin Treasury as a Service (BTaaS) platform provides institutional-grade infrastructure for listed firms adopting Bitcoin as a treasury asset. It allows clients to convert cash into Bitcoin, aggregate liquidity from leading exchanges to secure the best pricing, and produce accounting and compliance-ready reports for corporate disclosures.
CleanTech Lithium PLC (AIM:CTL, OTCQX:CTLHF) shares dropped in Monday morning's trade after announcing it had deferred payments under a purchase agreement for 23 Laguna Verde licences in Chile.
An original agreement, signed in April 2024, included milestone-based payments totalling US$35 million. The first payment of US$1.25 million has already been made, the company noted.
Strategic Minerals PLC (AIM:SML, OTC:SMCDF) shares shot up more than 25% in Monday's early trade after it completed three new drill holes at subsidiary Cornwall Resources Limited's (CRL) Redmoor tungsten-tin-copper project, in Cornwall.
All holes intersected the full thickness of the sheeted vein system, with logging indicating the presence of wolframite, cassiterite and chalcopyrite, the explorer said.
Chill Brands Group PLC (LSE:CHLL, OTCQB:CHBRF) has set out the next phase of its turnaround strategy, saying it has successfully transformed from an own-brand business into a diversified distributor and services group working with some of the world’s largest consumer goods companies.
The London-listed firm said it had “reinvented itself” over the past year, shedding loss-making operations in the US and focusing on the UK and European markets, where it now represents a growing list of global and emerging brands.
Atlantic Lithium Ltd (AIM:ALL, OTCQX:ALLIF, ASX:A11) has reported significant lithium-in-soil anomalies from Phase 2 and Phase 3 soil sampling across its 100%-owned Rubino and Agboville exploration licences in Côte d'Ivoire.
The Africa-focused explorer said the results confirm extensive lithium trends, while additional spodumene pegmatite occurrences have been identified through geological mapping.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has signed a Memorandum of Understanding (MoU) with WA biotech Marine Biomedical to expand its nerve, tendon and bone portfolio. The company will increase its stake from 1.72% to 11.70% for AU$1.05 million and gain first right of refusal on global distribution of Marine’s products, including the PearlBone™ bone substitute – a market estimated to be worth $US1.6 billion.
The companies will aim to sign a Formal Agreement within 30 business days of the MoU. The Subscription Agreement should then be completed within five business days of that signing.
Imugene Ltd (ASX:IMU, OTC:IUGNF) will showcase new data from its Neo-POLEM Phase II trial, investigating its PD1-Vaxx immunotherapy program in early-stage colorectal cancer, at this week’s European Society for Medical Oncology (ESMO) Congress 2025 in Berlin — one of the world’s leading forums for cancer research and innovation.
The company’s abstract, “Phase II trial of neoadjuvant PD-1 vaccine PD1-Vaxx in operable MSI-high colorectal cancer,” has been accepted for e-poster presentation at the five-day congress, which attracts more than 30,000 clinicians, researchers and industry specialists from around the world. The presentation will be delivered by Dr Tony Dhillon of the Royal Surrey NHS Foundation Trust in the UK.
Following on from its announcement last week that it had entered into a subscription agreement with US$3.5 billion gold mining, processing and refining company Lingbao Gold International Co. Ltd to raise US$10 million, Titan Minerals Ltd (ASX:TTM, OTC:TTTNF) has received the full amount in just three days.
The issue price of ~A$0.59 per share represents a 31% premium to Titan’s last closing price on October 13, 2025. Settlement and issue of the new shares are planned for Wednesday, October 22, 2025.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) has strengthened its balance sheet and strategic partnerships with a $2 million placement exclusively to Tribeca Investment Partners, further reinforcing its position within the United States’ fast-emerging critical minerals supply chain.
The deal follows Resolution’s well-supported $25 million capital raising earlier this month, providing additional momentum as the company advances exploration at its Horse Heaven Project in Idaho and progresses its downstream processing strategy aimed at supplying critical minerals to the US Government.